The pill, parity, and rheumatoid arthritis

Area of Science:

• Rheumatology
• Epidemiology
• Reproductive Health

Background:

• Rheumatoid arthritis (RA) is a chronic autoimmune disease with complex etiology.
• Factors influencing RA development, such as reproductive history and hormonal exposures, require further investigation.

Purpose of the Study:

• To examine the association between oral contraceptive pill (OCP) use, parity, and the risk of developing rheumatoid arthritis (RA).

Main Methods:

• A case-control study design was employed.
• Women with RA were compared against two control groups: women with osteoarthritis (OA) and women from a population-based electoral register.
• Statistical analysis included age-adjusted odds ratios and confidence intervals to assess risk factors.

Main Results:

• Nulliparity was identified as a significant risk factor for RA development.
• Oral contraceptive pill (OCP) use before age 35 showed a negative association with RA.
• A multiplicative interaction was observed: nulliparous non-OCP users had a four-fold increased RA risk compared to parous OCP users.

Conclusions:

• Pregnancy (parity) and oral contraceptive pill (OCP) use appear to have a protective effect against rheumatoid arthritis (RA).
• The underlying mechanisms for this observed protective effect warrant further research.